India's NIFTY Pharma Index Rises Following Budget Announcement

India's NIFTY Pharma Index experienced a 0.9% increase after the announcement of the country's budget plan. According to Jin10, the budget outlines a significant allocation of 100 billion rupees to the biopharmaceutical sector over the next five years. This move is expected to bolster the industry, providing a substantial boost to pharmaceutical companies and encouraging growth and innovation within the sector.